From Barron's 3-19-07 "CPE reported net income per diluted share of 27 cents, beating our estimate of 24 cents and matching consensus. Higher-than-expected production and realized pricing provided most of the upside to our estimate. Production in 4Q06...[was] up 216% year-over-year [but] vast majority of growth is due to post-hurricane restoration... We still think Callon is reasonably priced, trading at 4 times '08 estimated earnings before interest, taxes, depreciation and amortization. Yet due to reserve [declines], high leverage associated with the acquisition and...risk associated with having a majority of proven reserves in a single field, we're downgrading CPE from Outperform to Market Perform."

From Barron's 3-19-07 "Maintaining Buy and target of 28, which represents a 33 times multiple of our pro forma 2008E EPS of 72 cents, in line with CLRK's current multiple of 31 times our calendar-year '07 EPS estimate of 50 cents...[We believe] CLRK's three- to five-year earnings growth rate will be greater than 40%-45%. We expect to see the adoption of solid-state illumination gain momentum as the efficiency and pricing of LEDs [improve]. Given the sizeable opportunity and CLRK's position as a market leader, we believe that CLRK shares will command a high earnings multiple for many years to come."

From Barron's 3-19-07 "Upgrading to Peer Perform from Underperform. DLTR is currently trading at 8.4 times trailing Ebitda. In light of the announced takeover [of] Dollar General at an estimated 12 times trailing Ebitda, we believe the risk/reward is even. While DLTR has been able to drive top line sales effectively, operating income growth has lagged."

From Barron's 3-19-07 "Fourth-quarter loss exceeded expectations, but the company has sufficient cash to fund operations through the end of 2007. We believe the driver remains the Phase III MyVax data in follicular non-Hodgkins lymphoma that are expected in Q407. We remain cautious on the outcome of this trial. Given the binary nature of the data on GTOP's stock, we maintain our Hold rating."

From Barron's 3-19-07 "MAA has significantly underperformed its multifamily peers within the past several months, creating an attractive entry point. MAA shares trade at nearly a 25% discount to multifamily sector [funds-from-operations] multiples, and at a 15% [funds available for distribution] multiple discount. The current price represents a 9% discount to our $59.02 per share net-asset-value estimate. We are upgrading MAA from Market Perform to Outperform based on valuation."

From Barron's 3-19-07 "There's leveraged-buyout chatter stemming from a competitor who reports private-equity firms are assembling bids to pursue acquisition of BEE. We estimate net asset value at roughly 24 per share, but have been reluctant to upgrade BEE because: we're not wholly convinced CEO Laurence Geller is a willing seller now despite BEE's recent challenges; and concern that BEE may announce a significant multiyear renovation program that could be disruptive to future cash-flow growth, financial leverage, and ultimately NAV."

From Barron's 3-19-07 "While Wells Fargo's credit quality continues to hold up well, the stock could still be exposed to further headline risk should the subprime meltdown continue. Beyond that, there could be some modest risk to revenues through lower servicing fees or lower gains on the origination/sale of loans. At this point, we remain confident WFC will continue to post above-average revenue and earnings growth relative to most other large-cap banks. As such, we are leaving our 2007 and 2008 EPS estimates unchanged at $2.73 and $3.00, respectively. With the stock trading at a rare 5%-10% discount to the group, compared to a 10%-15% premium historically, we believe the recent selloff represents an attractive buying opportunity."